CompletedPhase 2NCT01222117
A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion
Studying Acute peripheral arterial occlusion
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Grifols Therapeutics LLC
- Principal Investigator
- Kecia CourtneyGrifols Therapeutics
- Intervention
- Plasmin(biological)
- Enrollment
- 174 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2010 – 2016
Study locations (30)
- Kaleida Health System, Buffalo, New York, United States
- Cleveland Clinic, Cleveland, Ohio, United States
- Ziekenhuis Oost Limburg, Campus St. Jan, Genk, Limburg, Belgium
- Erasme Hospital, Brussels, Brussels, Belgium
- University Hospital Antwerp, Edegem, Belgium
- Chirurgie UZ Leuven, Leuven, Belgium
- Clinic of Vascular Surgery and Angiology, Sofia, Bulgaria
- Tokuda Hospital Sofia, Sofia, Bulgaria
- Vascular Centre Vitkovicka Nemocnice, Ostrava - Vitkovice, Czechia
- Cevni Chirurgie, Nemocnice Na Homolce, Prague, Czechia
- IKEM, Kardiologicka klinika, Prague, Czechia
- University Hospital Kralovske Vinobrady, Prague, Czechia
- Chirurgicka klinika IPVZ, Ústí nad Labem, Czechia
- Universitätsklinikum Bonn, Radiologische Universitätsklinik, Bonn, Germany
- Universitäts GefäßCentrum Uniklinikum Dresden, Dresden, Germany
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01222117 on ClinicalTrials.gov